UPC APP 38165/2024

—·EP4087195: METHODS AND ARTICLES OF MANUFACTURE FOR HOSTING A SAFETY CRITICAL APPLICATION ON AN UNCONTROLLED DATA PROCESSING DEVICE

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Akteneinsicht (RoP262)
Parteien: Kläger
Abbott Diabetes Care Inc.
Vertreter: Dietrich Kamlah (Taylor Wessing); Christian Lederer (Taylor Wessing); Gisbert Hohagen (Taylor Wessing); Esslinger (Betten & Resch Partnerschaftsgesellschaft mbB)
Beklagte
DexCom, Inc.
Dexcom Deutschland GmbH
Dexcom International Limited
Vertreter: Marcus Grosch (Quinn Emanuel Urquhart & Sullivan LLP); Jérôme Kommer (Quinn Emanuel Urquhart & Sullivan LLP); Andreas Hahne (Quinn Emanuel Urquhart & Sullivan LLP); Armin Giesen (Quinn Emanuel Urquhart & Sullivan LLP); Maximilian Meier (Quinn Emanuel Urquhart & Sullivan LLP); Markus Müller (Hoffman Eitle); Eve O'Conner (Hoffman Eitle)
Division: Munich LD
Richter: Ulrike Voß · Presiding Judge / Judge-Rapporteur
Technology: Computing & AI
Sprache: —
Erste Entscheidung: 9. Aug. 2024

Entscheidungen

2024-08-09
Application RoP262A
The Munich Local Division issued a procedural order under Rule 262A RoP concerning the protection of confidential information submitted by the defendants in an infringement action regarding EP 4 087 195. No substantive patent ruling was made.
Rechtsfragen:Protection of confidential information (R. 262A RoP)Confidentiality of defendants' internal information

Dokumente